These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35803246)

  • 1. Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.
    Biermann J; Melms JC; Amin AD; Wang Y; Caprio LA; Karz A; Tagore S; Barrera I; Ibarra-Arellano MA; Andreatta M; Fullerton BT; Gretarsson KH; Sahu V; Mangipudy VS; Nguyen TTT; Nair A; Rogava M; Ho P; Koch PD; Banu M; Humala N; Mahajan A; Walsh ZH; Shah SB; Vaccaro DH; Caldwell B; Mu M; Wünnemann F; Chazotte M; Berhe S; Luoma AM; Driver J; Ingham M; Khan SA; Rapisuwon S; Slingluff CL; Eigentler T; Röcken M; Carvajal R; Atkins MB; Davies MA; Agustinus A; Bakhoum SF; Azizi E; Siegelin M; Lu C; Carmona SJ; Hibshoosh H; Ribas A; Canoll P; Bruce JN; Bi WL; Agrawal P; Schapiro D; Hernando E; Macosko EZ; Chen F; Schwartz GK; Izar B
    Cell; 2022 Jul; 185(14):2591-2608.e30. PubMed ID: 35803246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
    Fischer GM; Jalali A; Kircher DA; Lee WC; McQuade JL; Haydu LE; Joon AY; Reuben A; de Macedo MP; Carapeto FCL; Yang C; Srivastava A; Ambati CR; Sreekumar A; Hudgens CW; Knighton B; Deng W; Ferguson SD; Tawbi HA; Glitza IC; Gershenwald JE; Vashisht Gopal YN; Hwu P; Huse JT; Wargo JA; Futreal PA; Putluri N; Lazar AJ; DeBerardinis RJ; Marszalek JR; Zhang J; Holmen SL; Tetzlaff MT; Davies MA
    Cancer Discov; 2019 May; 9(5):628-645. PubMed ID: 30787016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases.
    Smalley I; Chen Z; Phadke M; Li J; Yu X; Wyatt C; Evernden B; Messina JL; Sarnaik A; Sondak VK; Zhang C; Law V; Tran N; Etame A; Macaulay RJB; Eroglu Z; Forsyth PA; Rodriguez PC; Chen YA; Smalley KSM
    Clin Cancer Res; 2021 Jul; 27(14):4109-4125. PubMed ID: 34035069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition.
    Alvarez-Breckenridge C; Markson SC; Stocking JH; Nayyar N; Lastrapes M; Strickland MR; Kim AE; de Sauvage M; Dahal A; Larson JM; Mora JL; Navia AW; Klein RH; Kuter BM; Gill CM; Bertalan M; Shaw B; Kaplan A; Subramanian M; Jain A; Kumar S; Danish H; White M; Shahid O; Pauken KE; Miller BC; Frederick DT; Hebert C; Shaw M; Martinez-Lage M; Frosch M; Wang N; Gerstner E; Nahed BV; Curry WT; Carter B; Cahill DP; Boland GM; Izar B; Davies MA; Sharpe AH; Suvà ML; Sullivan RJ; Brastianos PK; Carter SL
    Cancer Immunol Res; 2022 Aug; 10(8):996-1012. PubMed ID: 35706413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.
    Karz A; Dimitrova M; Kleffman K; Alvarez-Breckenridge C; Atkins MB; Boire A; Bosenberg M; Brastianos P; Cahill DP; Chen Q; Ferguson S; Forsyth P; Glitza Oliva IC; Goldberg SB; Holmen SL; Knisely JPS; Merlino G; Nguyen DX; Pacold ME; Perez-Guijarro E; Smalley KSM; Tawbi HA; Wen PY; Davies MA; Kluger HM; Mehnert JM; Hernando E
    Pigment Cell Melanoma Res; 2022 Nov; 35(6):554-572. PubMed ID: 35912544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.
    Sloot S; Chen YA; Zhao X; Weber JL; Benedict JJ; Mulé JJ; Smalley KS; Weber JS; Zager JS; Forsyth PA; Sondak VK; Gibney GT
    Cancer; 2018 Jan; 124(2):297-305. PubMed ID: 29023643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.
    Ramos RI; Bustos MA; Wu J; Jones P; Chang SC; Kiyohara E; Tran K; Zhang X; Stern SL; Izraely S; Sagi-Assif O; Witz IP; Davies MA; Mills GB; Kelly DF; Irie RF; Hoon DSB
    Mol Oncol; 2020 Aug; 14(8):1760-1778. PubMed ID: 32358995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic Zuclopenthixol Inhibits Melanoma Growth and Brain Metastasis by Inducing Apoptosis and Cell Cycle Arrest.
    Lin W; Xia Y; He A; Chen S; Zhang J
    Front Biosci (Landmark Ed); 2024 Mar; 29(4):132. PubMed ID: 38682202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy.
    Ahmed KA; Abuodeh YA; Echevarria MI; Arrington JA; Stallworth DG; Hogue C; Naghavi AO; Kim S; Kim Y; Patel BG; Sarangkasiri S; Johnstone PA; Sahebjam S; Khushalani NI; Forsyth PA; Harrison LB; Yu M; Etame AB; Caudell JJ
    Ann Oncol; 2016 Dec; 27(12):2288-2294. PubMed ID: 27637745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Treatment of Melanoma Brain Metastasis.
    Rishi A; Yu HM
    Curr Treat Options Oncol; 2020 Apr; 21(6):45. PubMed ID: 32350685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.
    Bander ED; Yuan M; Carnevale JA; Reiner AS; Panageas KS; Postow MA; Tabar V; Moss NS
    Cancer; 2021 Jun; 127(12):2062-2073. PubMed ID: 33651913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control.
    Alvarez-Breckenridge C; Giobbie-Hurder A; Gill CM; Bertalan M; Stocking J; Kaplan A; Nayyar N; Lawrence DP; Flaherty KT; Shih HA; Oh K; Batchelor TT; Cahill DP; Sullivan R; Brastianos PK
    Oncologist; 2019 May; 24(5):671-679. PubMed ID: 30796152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.
    Pozzi S; Scomparin A; Ben-Shushan D; Yeini E; Ofek P; Nahmad AD; Soffer S; Ionescu A; Ruggiero A; Barzel A; Brem H; Hyde TM; Barshack I; Sinha S; Ruppin E; Weiss T; Madi A; Perlson E; Slutsky I; Florindo HF; Satchi-Fainaro R
    JCI Insight; 2022 Sep; 7(17):. PubMed ID: 35980743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
    Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
    Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases.
    Gellert J; Agardy DA; Kumar S; Kourtesakis A; Boschert T; Jähne K; Breckwoldt MO; Bunse L; Wick W; Davies MA; Platten M; Bunse T
    Cancer Res Commun; 2024 Aug; 4(8):2189-2202. PubMed ID: 39056192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
    Marzese DM; Scolyer RA; Roqué M; Vargas-Roig LM; Huynh JL; Wilmott JS; Murali R; Buckland ME; Barkhoudarian G; Thompson JF; Morton DL; Kelly DF; Hoon DS
    Neuro Oncol; 2014 Nov; 16(11):1499-509. PubMed ID: 24968695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of systemic therapy in melanoma brain metastases: a narrative review.
    Saleem K; Davar D
    Chin Clin Oncol; 2022 Jun; 11(3):24. PubMed ID: 35818856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.
    Marzese DM; Liu M; Huynh JL; Hirose H; Donovan NC; Huynh KT; Kiyohara E; Chong K; Cheng D; Tanaka R; Wang J; Morton DL; Barkhoudarian G; Kelly DF; Hoon DS
    Pigment Cell Melanoma Res; 2015 Jan; 28(1):82-93. PubMed ID: 25169209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MET receptor serves as a promising target in melanoma brain metastases.
    Redmer T; Schumann E; Peters K; Weidemeier ME; Nowak S; Schroeder HWS; Vidal A; Radbruch H; Lehmann A; Kreuzer-Redmer S; Jürchott K; Radke J
    Acta Neuropathol; 2024 Feb; 147(1):44. PubMed ID: 38386085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.